MDL 3017 — Xarelto (Rivaroxaban) ('310) Patent Litigation

Off the roster — last appeared 2026-01-05, which usually means the litigation resolved, settled, or closed.

Pending actions over time

Civil actions pending in this MDL, from JPML's monthly Actions-Pending reports.

Roster timeline

Each cell is one monthly JPML report (2014-02-19 → 2026-08-03); filled cells are months this MDL was on the pending roster.

Related Patent & IP

• MDL 3176 — Rare Breed Triggers Patent Litigation — 59 pending
• MDL 3143 — OpenAI, Inc., Copyright Infringement Litigation — 19 pending
• MDL 3138 — Denosumab Patent Litigation — 8 pending
• MDL 3034 — Neo Wireless, LLC, Patent Litigation — 7 pending
• MDL 3103 — Aflibercept Patent Litigation — 3 pending
• MDL 3134 — AVYCAZ (Ceftazidime and Avibactam) Patent Litigation — 2 pending

All patent & ip MDLs →

Sources

• JPML Pending MDLs (official)
• Roster report containing this row

Roster presence is our derivation from JPML's monthly PDFs; confirm current status with the court before relying on it.